Viracta Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | Buy€45,447 | Mark Rothera | Individual | 100,000 | €0.45 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,059,760 | 2.69% |
Hedge Funds | 3,614,662 | 9.17% |
Institutions | 6,437,469 | 16.3% |
VC/PE Firms | 9,959,759 | 25.3% |
General Public | 18,345,521 | 46.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,392,237 | €1.5m | 0% | 2.75% | |||
3,614,662 | €730.9k | 0% | 0.02% | |||
2,567,522 | €519.2k | 0% | 100.0% | |||
1,520,240 | €307.4k | -2.87% | no data | |||
1,161,280 | €234.8k | 0% | no data | |||
1,016,173 | €205.5k | -11.9% | 0.01% | |||
833,121 | €168.5k | 3.12% | no data | |||
689,709 | €139.5k | 0% | 0.03% | |||
407,299 | €82.4k | -3.12% | no data | |||
288,571 | €58.3k | 0% | 0.03% | |||
273,297 | €55.3k | -10.1% | no data | |||
270,773 | €54.8k | 7.15% | no data | |||
217,699 | €44.0k | 7.51% | no data | |||
134,544 | €27.2k | 14% | no data | |||
117,444 | €23.7k | 8.33% | no data | |||
109,195 | €22.1k | 6.73% | no data | |||
74,000 | €15.0k | 0% | no data | |||
65,867 | €13.3k | 0% | no data | |||
61,601 | €12.5k | -2.85% | no data | |||
38,104 | €7.7k | -0.23% | no data | |||
30,789 | €6.2k | 0% | no data | |||
27,417 | €5.5k | -92.5% | no data | |||
19,201 | €3.9k | 13% | no data | |||
15,000 | €3.0k | -14.3% | no data | |||
15,000 | €3.0k | 0% | no data |